LBT Innovations Limited (AU:LBT) has released an update.
LBT Innovations Limited, an Australian medical technology firm, will be highlighted at a prestigious investment conference focusing on digital assets, AI, and technology in Sydney. The company specializes in microbiology automation and is recognized for its FDA-cleared artificial intelligence technology, APAS® Independence, which is revolutionizing the analysis of microbiology culture plates. This cutting-edge product is marketed to both pharmaceutical and clinical laboratories and is distributed by industry giant Thermo Fisher Scientific in the US and parts of Europe.
For further insights into AU:LBT stock, check out TipRanks’ Stock Analysis page.
